- Home
- APLT vs ABVE Comparison
APLT vs ABVE Comparison
Compare APLT & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- ABVE
- Stock Information
- Founded
- APLT 2016
- ABVE 2019
- Country
- APLT United States
- ABVE Canada
- Employees
- APLT N/A
- ABVE N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- ABVE Packaged Foods
- Sector
- APLT Health Care
- ABVE Consumer Staples
- Exchange
- APLT Nasdaq
- ABVE Nasdaq
- Market Cap
- APLT 44.0M
- ABVE 35.9M
- IPO Year
- APLT 2019
- ABVE N/A
- Fundamental
- Price
- APLT $0.45
- ABVE $1.68
- Analyst Decision
- APLT Buy
- ABVE
- Analyst Count
- APLT 7
- ABVE 0
- Target Price
- APLT $6.10
- ABVE N/A
- AVG Volume (30 Days)
- APLT 1.6M
- ABVE 50.1M
- Earning Date
- APLT 08-11-2025
- ABVE 02-15-2025
- Dividend Yield
- APLT N/A
- ABVE N/A
- EPS Growth
- APLT N/A
- ABVE N/A
- EPS
- APLT N/A
- ABVE N/A
- Revenue
- APLT $265,000.00
- ABVE $213,446,206.00
- Revenue This Year
- APLT $415.60
- ABVE N/A
- Revenue Next Year
- APLT $1,323.96
- ABVE N/A
- P/E Ratio
- APLT N/A
- ABVE N/A
- Revenue Growth
- APLT N/A
- ABVE N/A
- 52 Week Low
- APLT $0.30
- ABVE $0.25
- 52 Week High
- APLT $10.62
- ABVE $4.40
- Technical
- Relative Strength Index (RSI)
- APLT 53.55
- ABVE N/A
- Support Level
- APLT $0.46
- ABVE N/A
- Resistance Level
- APLT $0.54
- ABVE N/A
- Average True Range (ATR)
- APLT 0.05
- ABVE 0.00
- MACD
- APLT -0.00
- ABVE 0.00
- Stochastic Oscillator
- APLT 53.66
- ABVE 0.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About ABVE Above Food Ingredients Inc. Common Stock
Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.